Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF

This publication has 14 references indexed in Scilit:

• The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
  British Journal of Cancer, 1996
• The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas
  Cancer Letters, 1995
• Thymidine phosphorylase is angiogenic and promotes tumor growth.
  Proceedings of the National Academy of Sciences, 1995
• Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth Factor
  JNCI Journal of the National Cancer Institute, 1994
• Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines
  British Journal of Cancer, 1993
• Evaluating the Potential Usefulness of New Prognostic and Predictive Indicators on Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1993
• Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1990
• Substrate specificity of a thymidine phosphorylase in human liver tumor.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
• The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriation
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1980
• Identification and Comparative Analysis of Thymidine Phosphorylase in the Plasma of Healthy Subjects and Cancer Patients: Brief Communication 2
  JNCI Journal of the National Cancer Institute, 1977